Your session is about to expire
← Back to Search
Perampanel for Status Epilepticus
Study Summary
This trial aims to understand epilepsy treatment better and see if a new drug is safe and effective. 25 patients will be tested and monitored for 96 weeks.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2021 Phase 4 trial • 54 Patients • NCT03288129Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am cautious with medications that affect liver enzymes, like some seizure drugs.My seizures are due to a lack of oxygen to the brain.I have liver problems.I have had seizures caused by very low or high blood sugar.I have a history of mental health issues or thoughts of harming myself.I am 18 years old or older.I have severe kidney problems or am on dialysis.You have a severe allergy to any anti-epileptic drug (AED).I have severe epilepsy that didn't stop after two types of medication.I have used or am currently using PMP.I use oral contraception and am open to discussing other methods.I am not pregnant or have a negative pregnancy test if capable of becoming pregnant.I am not taking medications like Rifampin or St John's Wort.
- Group 1: Single arm prospective study
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is eligibility for the trial limited to individuals under 35 or can those of greater age participate?
"This clinical trial welcomes all participants over the age of majority, up to a cap of 100 years old."
How can patients be guaranteed a level of security when partaking in single-arm prospective studies?
"Single arm prospective study is an approved treatment, so our team rated its safety a 3."
Is enrollment still ongoing for this study?
"The clinical trial, first posted on February 1st 2023 and last modified on June 1st of the same year, is no longer open to new participants. However, 11 other investigations are currently recruiting patients."
Am I eligible to become a participant in this investigation?
"This clinical trial is seeking 25 individuals aged 18 to 100 with refractory status epilepticus. To qualify, subjects must satisfy certain conditions such as being over the age of majority and requiring IV anaesthetic infusions for RSE which has been unresponsive to benzodiazepines and anti-epileptic drugs (AEDs). Additionally, female participants taking oral birth control pills should be made aware of other contraceptive options if they plan on participating in this study long term."
Share this study with friends
Copy Link
Messenger